Combined remodeling control therapy and anti-remodeling therapy by implantable cardiac device
US8838239B2 · kind B2 · utility
1Cited by
78References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2013 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Jul 8, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36114
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method and device for delivering ventricular resynchronization pacing therapy in conjunction with electrical stimulation of nerves which alter the activity of the autonomic nervous system is disclosed. Such therapies may be delivered by an implantable device and are useful in preventing the deleterious ventricular remodeling which occurs as a result of a heart attack or heart failure. The device may perform an assessment of cardiac function in order to individually modulate the delivery of the two types of therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.